Assessment of Thermal Stability of Mutant p53 Proteins via Differential Scanning Fluorimetry

por Khadiullina, Raniya, Mirgayazova, Regina, Davletshin, Damir, Khusainova, Elvina, Chasov, Vitaly, Bulatov, Emil
Publicado 2022

Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?

por Mirgayazova, Regina, Khadiullina, Raniya, Chasov, Vitaly, Mingaleeva, Rimma, Miftakhova, Regina, Rizvanov, Albert, Bulatov, Emil
Publicado 2020

Novel Isatin-based activator of p53 transcriptional functions in tumor cells

por Mirgayazova, Regina, Khadiullina, Raniya, Mingaleeva, Rimma, Chasov, Vitaly, Gomzikova, Marina, Garanina, Ekaterina, Rizvanov, Albert, Bulatov, Emil
Publicado 2019

USP7 Inhibitors in Cancer Immunotherapy: Current Status and Perspective

por Korenev, Georgiy, Yakukhnov, Sergey, Druk, Anastasia, Golovina, Anastasia, Chasov, Vitaly, Mirgayazova, Regina, Ivanov, Roman, Bulatov, Emil
Publicado 2022

Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies

por Chasov, Vitaly, Zaripov, Mikhail, Mirgayazova, Regina, Khadiullina, Raniya, Zmievskaya, Ekaterina, Ganeeva, Irina, Valiullina, Aigul, Rizvanov, Albert, Bulatov, Emil
Publicado 2021

Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy

por Chasov, Vitaly, Mirgayazova, Regina, Zmievskaya, Ekaterina, Khadiullina, Raniya, Valiullina, Aygul, Stephenson Clarke, Joseph, Rizvanov, Albert, Baud, Matthias G. J., Bulatov, Emil
Publicado 2020